Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Cheryl E Hickmann, Diego Castanares-Zapatero, Louise Deldicque, Peter Van den Bergh, Gilles Caty, Annie Robert, Jean Roeseler, Marc Francaux, Pierre-François Laterre, Cheryl E Hickmann, Diego Castanares-Zapatero, Louise Deldicque, Peter Van den Bergh, Gilles Caty, Annie Robert, Jean Roeseler, Marc Francaux, Pierre-François Laterre

Abstract

Objectives: As the catabolic state induced by septic shock together with the physical inactivity of patients lead to the rapid loss of muscle mass and impaired function, the purpose of this study was to test whether an early physical therapy during the onset of septic shock regulates catabolic signals and preserves skeletal muscle mass.

Design: Randomized controlled trial.

Setting: Tertiary mixed ICU.

Patients: Adult patients admitted for septic shock within the first 72 hours.

Interventions: Patients were assigned randomly into two groups. The control group benefited from manual mobilization once a day. The intervention group had twice daily sessions of both manual mobilization and 30-minute passive/active cycling therapy.

Measurements and main results: Skeletal muscle biopsies and electrophysiology testing were performed at day 1 and day 7. Muscle biopsies were analyzed for histology and molecular components of signaling pathways regulating protein synthesis and degradation as well as inflammation markers. Hemodynamic values and patient perception were collected during each session. Twenty-one patients were included. Three died before the second muscle biopsy. Ten patients in the control and eight in the intervention group were analyzed. Markers of the catabolic ubiquitin-proteasome pathway, muscle atrophy F-box and muscle ring finger-1 messenger RNA, were reduced at day 7 only in the intervention group, but without difference between groups (muscle atrophy F-box: -7.3% ± 138.4% in control vs -56.4% ± 37.4% in intervention group; p = 0.23 and muscle ring finger-1: -30.8% ± 66.9% in control vs -62.7% ± 45.5% in intervention group; p = 0.15). Muscle fiber cross-sectional area (µm) was preserved by exercise (-25.8% ± 21.6% in control vs 12.4% ± 22.5% in intervention group; p = 0.005). Molecular regulations suggest that the excessive activation of autophagy due to septic shock was lower in the intervention group, without being suppressed. Markers of anabolism and inflammation were not modified by the intervention, which was well tolerated by the patients.

Conclusions: Early physical therapy during the first week of septic shock is safe and preserves muscle fiber cross-sectional area.

Trial registration: ClinicalTrials.gov NCT01787045.

Figures

Figure 1.
Figure 1.
Amount of mobility activities performed per patient during the first week.
Figure 2.
Figure 2.
A, Quantitative analysis of double immunologic stain LAMP2-p62 by groups. B, Quantitative analysis of double immunologic stain LC3b-p62 by groups. Double immunologic stain. p* represents p values from difference between day 1 and day 7 for each group; p** represents p values from difference between changes of control and intervention groups. C, Representative images of double immunological stain. Pompe disease sample was used as positive control of elevated autophagy. LAMP2 = lysosomal-associated membrane protein 2, LC3b = microtubule-associated protein 1 light chain 3 beta, p62 = sequestosome 1. LAMP2 or LC3b positive areas are brown and p62 positive areas are red.
Figure 3.
Figure 3.
Muscle fiber cross-sectional area changes by group. Skeletal muscle sections stained with adenosine triphosphatase pH 4.50; black fibers correspond to type-I fibers; gray fibers are type-IIb fibers and; pink fibers correspond to type-IIa.

References

    1. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit Care Med 2012; 40:502–509..
    1. Witteveen E, Wieske L, van der Poll T, et al. ; Molecular Diagnosis and Risk Stratification of Sepsis (MARS) Consortium: Increased early systemic inflammation in ICU-acquired weakness; a prospective observational cohort study. Crit Care Med 2017; 45:972–979..
    1. Nanas S, Kritikos K, Angelopoulos E, et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008; 118:175–181..
    1. Biolo G. Protein metabolism and requirements. World Rev Nutr Diet 2013; 105:12–20..
    1. Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014; 370:1626–1635..
    1. Weijs PJ, Looijaard WG, Dekker IM, et al. Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Crit Care 2014; 18:R12.
    1. Ali NA, O’Brien JM, Jr, Hoffmann SP, et al. ; Midwest Critical Care Consortium: Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178:261–268..
    1. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009; 37:S299–S308..
    1. Tennilä A, Salmi T, Pettilä V, et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000; 26:1360–1363..
    1. Tepper M, Rakic S, Haas JA, et al. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000; 56:211–214..
    1. Klaude M, Mori M, Tjäder I, et al. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond) 2012; 122:133–142..
    1. Sandri M. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am J Physiol Cell Physiol 2010; 298:C1291–C1297..
    1. Hermans G, De Jonghe B, Bruyninckx F, et al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014; (1):CD006832.
    1. Kayambu G, Boots R, Paratz J. Physical therapy for the critically ill in the ICU: A systematic review and meta-analysis. Crit Care Med 2013; 41:1543–1554..
    1. Stiller K. Physiotherapy in intensive care: An updated systematic review. Chest 2013; 144:825–847..
    1. Kayambu G, Boots R, Paratz J. Early physical rehabilitation in intensive care patients with sepsis syndromes: A pilot randomised controlled trial. Intensive Care Med 2015; 41:865–874..
    1. Hermans G, Van den Berghe G. Clinical review: Intensive care unit acquired weakness. Crit Care 2015; 19:274.
    1. Helliwell TR, Wilkinson A, Griffiths RD, et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998; 24:507–517..
    1. Hickmann CE, Castanares-Zapatero D, Bialais E, et al. Teamwork enables high level of early mobilization in critically ill patients. Ann Intensive Care 2016; 6:80.
    1. Pohlman MC, Schweickert WD, Pohlman AS, et al. Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med 2010; 38:2089–2094..
    1. D’Hulst G, Jamart C, Van Thienen R, et al. Effect of acute environmental hypoxia on protein metabolism in human skeletal muscle. Acta Physiol (Oxf) 2013; 208:251–264..
    1. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14:1103–1109..
    1. Lee H, Ko YJ, Suh GY, et al. Safety profile and feasibility of early physical therapy and mobility for critically ill patients in the medical intensive care unit: Beginning experiences in Korea. J Crit Care 2015; 30:673–677..
    1. McClave SA, Martindale RG, Vanek VW, et al. ; A.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009; 33:277–316..
    1. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117:399–412..
    1. Penna F, Baccino FM, Costelli P. Coming back: Autophagy in cachexia. Curr Opin Clin Nutr Metab Care 2014; 17:241–246..
    1. Steiner JL, Crowell KT, Kimball SR, et al. Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle. Am J Physiol Endocrinol Metab 2015; 309:E981–E994..
    1. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: Myopathy or neuropathy–a reappraisal. Clin Neurophysiol 2001; 112:1586–1593..
    1. Weber-Carstens S, Koch S, Spuler S, et al. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009; 37:2632–2637..
    1. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet 2009; 373:1874–1882..
    1. Fan E, Cheek F, Chlan L, et al. ; ATS Committee on ICU-acquired Weakness in Adults; American Thoracic Society: An official American Thoracic Society Clinical Practice guideline: The diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014; 190:1437–1446..
    1. Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med 2009; 37:S354–S367..
    1. Dumont N, Bouchard P, Frenette J. Neutrophil-induced skeletal muscle damage: A calculated and controlled response following hindlimb unloading and reloading. Am J Physiol Regul Integr Comp Physiol 2008; 295:R1831–R1838..
    1. Puthucheary Z, Montgomery H, Moxham J, et al. Structure to function: Muscle failure in critically ill patients. J Physiol 2010; 588:4641–4648..
    1. Poulsen JB, Møller K, Jensen CV, et al. Effect of transcutaneous electrical muscle stimulation on muscle volume in patients with septic shock. Crit Care Med 2011; 39:456–461..
    1. Dirks ML, Hansen D, Van Assche A, et al. Neuromuscular electrical stimulation prevents muscle wasting in critically ill comatose patients. Clin Sci (Lond) 2015; 128:357–365..
    1. Segers J, Hermans G, Bruyninckx F, et al. Feasibility of neuromuscular electrical stimulation in critically ill patients. J Crit Care 2014; 29:1082–1088..
    1. Hermans G, Casaer MP, Clerckx B, et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: A subanalysis of the EPaNIC trial. Lancet Respir Med 2013; 1:621–629..
    1. Crowell KT, Soybel DI, Lang CH. Restorative mechanisms regulating protein balance in skeletal muscle during recovery from sepsis. Shock 2017; 47:463–473..
    1. Jespersen JG, Nedergaard A, Reitelseder S, et al. Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients. PLoS One 2011; 6:e18090.
    1. Laghi F, Khan N, Schnell T, et al. New device for nonvolitional evaluation of quadriceps force in ventilated patients. Muscle Nerve 2018; 57:784–791..

Source: PubMed

3
Suscribir